Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach [Original Articles]

Conclusions— In HF with preserved ejection fraction, novel biomarkers of inflammation predict HF severity and prognosis that may complement or even outperform traditional markers, such as N-terminal probrain natriuretic peptide. These findings lend support to a hypothesis implicating global systemic inflammation in HF with preserved ejection fraction. Clinical Trial Registration— URL: http://www.clinicaltrials.gov; Unique identifier: NCT00774709.

http://circgenetics.ahajournals.org/cgi/content/short/10/1/e001633?rss=1

Source: Circulation: Cardiovascular Genetics - January 17, 2017 Category: Cardiology Authors: Hage, C., Michaelsson, E., Linde, C., Donal, E., Daubert, J.-C., Gan, L.-M., Lund, L. H. Tags: Heart Failure Original Articles Source Type: research